CardioSolv™ is an early stage company developing new strategies to improve the treatment of patients with ventricular tachycardia (VT).
Heart failure can occur at any age and has many causes; in adults it is most commonly caused by narrowings in the arteries that supply the heart muscle (coronary artery d...
Drugs primarily affecting the functional activity of the cardiovascular system, represent a very large group of drugs of different mechanism of action, elicit their effec...
Department of Anaesthesia & Intensive Care, Papworth Hospital, Cambridge, UK.
« 1 » |
